Annual Shareholders Equity
$253.90 M
+$56.35 M+28.52%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual stockholders equity is $253.90 million, with the most recent change of +$56.35 million (+28.52%) on December 31, 2023.
- During the last 3 years, OLMA annual shareholders equity has fallen by -$84.24 million (-24.91%).
- OLMA annual shareholders equity is now -24.91% below its all-time high of $338.14 million, reached on December 31, 2020.
Performance
OLMA Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$198.91 M
-$28.25 M-12.44%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly stockholders equity is $198.91 million, with the most recent change of -$28.25 million (-12.44%) on September 30, 2024.
- Over the past year, OLMA quarterly shareholders equity has dropped by -$76.22 million (-27.70%).
- OLMA quarterly shareholders equity is now -41.17% below its all-time high of $338.14 million, reached on December 31, 2020.
Performance
OLMA Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
OLMA Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +28.5% | -27.7% |
3 y3 years | -24.9% | -27.7% |
5 y5 years | +4144.2% | -27.7% |
OLMA Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -10.8% | +28.5% | -30.1% | +23.1% |
5 y | 5-year | -24.9% | +2496.6% | -41.2% | +1977.6% |
alltime | all time | -24.9% | +2496.6% | -41.2% | +1977.6% |
Olema Pharmaceuticals Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $198.91 M(-12.4%) |
Jun 2024 | - | $227.16 M(-3.9%) |
Mar 2024 | - | $236.32 M(-6.9%) |
Dec 2023 | $253.90 M(+28.5%) | $253.90 M(-7.7%) |
Sep 2023 | - | $275.13 M(+70.3%) |
Jun 2023 | - | $161.58 M(-7.7%) |
Mar 2023 | - | $174.97 M(-11.4%) |
Dec 2022 | $197.55 M | $197.55 M(-9.3%) |
Sep 2022 | - | $217.70 M(-7.9%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $236.28 M(-10.9%) |
Mar 2022 | - | $265.09 M(-6.8%) |
Dec 2021 | $284.57 M(-15.8%) | $284.57 M(-5.4%) |
Sep 2021 | - | $300.89 M(-4.2%) |
Jun 2021 | - | $314.08 M(-3.7%) |
Mar 2021 | - | $326.02 M(-3.6%) |
Dec 2020 | $338.14 M(-3291.8%) | $338.14 M(+169.6%) |
Sep 2020 | - | $125.41 M(-1283.8%) |
Dec 2019 | -$10.59 M(+68.7%) | -$10.59 M |
Dec 2018 | -$6.28 M | - |
FAQ
- What is Olema Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual shareholders equity year-on-year change?
- What is Olema Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Olema Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of OLMA is $253.90 M
What is the all time high annual shareholders equity for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual stockholders equity is $338.14 M
What is Olema Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, OLMA annual stockholders equity has changed by +$56.35 M (+28.52%)
What is Olema Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of OLMA is $198.91 M
What is the all time high quarterly shareholders equity for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly stockholders equity is $338.14 M
What is Olema Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, OLMA quarterly stockholders equity has changed by -$76.22 M (-27.70%)